Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $3.34 USD
Change Today +0.06 / 1.83%
Volume 377.6K
RIGL On Other Exchanges
Symbol
Exchange
Frankfurt
As of 8:10 PM 03/27/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Donald G. Payan M.D.

Co-Founder, Executive Vice President, Director and President of Discovery & Research, Rigel Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 6 board members in 1 different organizations across 3 different industries.

See Board Relationships
65--
As of Fiscal Year 2013

Background*

Dr. Donald G. Payan, M.D. is a Co-Founder of Rigel Pharmaceuticals, Inc. and has been its Executive Vice President since January 1997. Dr. Payan has been President of Discovery and Research at Rigel Pharmaceuticals, Inc. since February 2008. He served as the Chief Scientific Officer of Rigel Pharmaceuticals, Inc. since January 1997. He served as President and Chief Executive Officer of Rigel Pharmaceuticals, Inc. from July 1996 to January 1997 and also served as its ...

Read Full Background

Corporate Headquarters*

1180 Veterans Boulevard
South San Francisco, California 94080

United States

Phone: 650-624-1100
Fax: 650-624-1101

Board Members Memberships*

Former Director
1996-Present
Co-Founder, Executive Vice President, Director and President of Discovery & Research

Education*

BS
Stanford University
MD
Stanford University

Other Affiliations*

There is no Company Affiliations data available.

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
RIGL:US $3.34 USD +0.06

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact RIGEL PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.